Navigation Links
FDA: Minnesota Companies Agree to Halt Sale of Amino-acid Products with Unapproved Claims

SILVER SPRING, Md., Sept. 14, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that two Minnesota companies have agreed to halt distribution of amino-acid products marketed to treat a number of diseases, until requirements of the Federal Food, Drug, and Cosmetic Act are met.


West Duluth Distribution Co., a corporation doing business as CHK Nutrition, and NeuroResearch Clinics Inc., both of Duluth, Minn., and their owners or principals, signed a consent decree of permanent injunction, which was entered by the U.S. District Court for the District of Minnesota on September 13.

The complaint for permanent injunction alleges that the companies violated the Federal Food, Drug and Cosmetic Act. As alleged in the complaint, CHK Nutrition's amino-acid products are marketed with claims that they may cure, mitigate, or treat diseases. The products are not the subject of approved new drug applications nor do they qualify for exemption from the premarket approval process as investigational new drugs. Therefore, the amino-acid products are unapproved new drugs within the meaning of the Act.

The consent decree prohibits the defendants from distributing any of their amino-acid products into interstate commerce unless and until they remove the drug claims from their websites. The defendants also agreed to hire an expert to review the claims they make for their products and certify that they have omitted all violative claims. Under the decree, FDA can order the defendants to stop distributing their amino-acid products if they fail to comply with the Act or the terms of the decree.  

"By ensuring that CHK Nutrition and NeuroResearch can't distribute these unapproved products, FDA is helping to prevent health risks for consumers that might take these drugs or delay other important treatments," said Dara A. Corrigan, the FDA's associate commissioner for regulatory affairs. "Until these companies meet FDA requirements, they will no longer be able to process or distribute their products."  

The FDA conducted an inspection of CHK Nutrition and NeuroResearch Clinics in July 2010. During that inspection, an FDA investigator observed evidence of the coordination of the sale of CHK Nutrition's products with claims that such products are effective treatments for "neurotransmitter diseases."

In September 2010, the FDA reviewed CHK Nutrition's website and observed a link to NeuroResearch Clinics' website containing extensive discussions about "amino-acid therapy" for the treatment of Parkinson's disease, Alzheimer's disease, depression, obsessive-compulsive disorder, attention-deficit hyperactivity disorder, fibromyalgia, and others.

Despite FDA warnings to stop making unapproved drug claims, CHK Nutrition and NeuroResearch Clinics did not do so.  The FDA conducted a follow-up review of the companies' websites in February 2011 and found an ongoing connection between the sale of CHK Nutrition's products and claims that they can be used to treat diseases.  The FDA believes that, unless restrained by a court, the companies would continue to violate the law.

For more information:

Dietary Supplements

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.


Visit the FDA on Facebook

RSS Feed for FDA News Releases [what is RSS?]

Media Inquiries: Tamara Ward, 301-796-7567;
Consumer Inquiries: 888-INFO-FDA

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Coloplast Selected By LifeScience Alley to Host Minnesota Medical Device Panel
2. Prime Therapeutics President and CEO Eric Elliott Delivers Speech at University of Minnesota College of Pharmacy Dialogues in Managed Care Leadership 2011
3. BioDrain Medical, Inc. Completes Installation of Its Streamway™ Automated Surgical Fluid Disposal System in Minnesota Hospital
4. New Report from Childrens Hospitals and Clinics Shows Vaccination Rates Declining among Minnesota Children
5. Minnesotans Help Produce As Well As Benefit from Lifesaving Therapies
6. Heart Device Manufacturer in Minnesota and Hospitals in Ohio & Kentucky to Pay Nearly $4 Million to Resolve Fraud Allegations
7. Childrens Hospitals and Clinics of Minnesota Teams With Geek Squad to Open First Ever In-Hospital Precinct
8. Minnesota High School Tournament Sidelines to be More Secure From Sudden Cardiac Arrest
9. Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
10. Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity
11. ZINO Society, ZZIF Companies Announced
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):